Citations (35)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (1)
Alessio Molfino, Maria Ida Amabile, Antonella Giorgi, Massimo Monti, Vito D’Andrea & Maurizio Muscaritoli. (2019) Investigational drugs for the treatment of cancer cachexia: a focus on phase I and phase II clinical trials. Expert Opinion on Investigational Drugs 28:8, pages 733-740.
Read now
Read now
Articles from other publishers (34)
Jung Yoon Jang, Donghwan Kim & Nam Deuk Kim. (2023) Pathogenesis, Intervention, and Current Status of Drug Development for Sarcopenia: A Review. Biomedicines 11:6, pages 1635.
Crossref
Crossref
Tania Setiawan, Ita Novita Sari, Yoseph Toni Wijaya, Nadya Marcelina Julianto, Jabir Aliyu Muhammad, Hyeok Lee, Ji Heon Chae & Hyog Young Kwon. (2023) Cancer cachexia: molecular mechanisms and treatment strategies. Journal of Hematology & Oncology 16:1.
Crossref
Crossref
Ruoxin Fang, Ling Yan & Zhengkai Liao. (2023) Abnormal lipid metabolism in cancer-associated cachexia and potential therapy strategy. Frontiers in Oncology 13.
Crossref
Crossref
Song Gao, Guohua Zhang, Zicheng Zhang, James Z. Zhu, Li Li, Yong Zhou, George G. RodneyJr.Jr., Reem S. Abo-Zahrah, Lindsey Anderson, Jose M. Garcia, Yong Tae Kwon & Yi-Ping Li. (2022) UBR2 targets myosin heavy chain IIb and IIx for degradation: Molecular mechanism essential for cancer-induced muscle wasting. Proceedings of the National Academy of Sciences 119:43.
Crossref
Crossref
Zhelong Liu, Jian Xiong, Song Gao, Michael X. Zhu, Kai Sun, Min Li, Guohua Zhang & Yi‐Ping Li. (2021) Ameliorating cancer cachexia by inhibiting cancer cell release of Hsp70 and Hsp90 with omeprazole. Journal of Cachexia, Sarcopenia and Muscle 13:1, pages 636-647.
Crossref
Crossref
Kairu Xie, Hairong Xiong, Wen Xiao, Zhiyong Xiong, Wenjun Hu, Jiaxin Ye, Ning Xu, Jian Shi, Changfei Yuan, Zhixian Chen, Daojia Miao, Xiaoping Zhang & Hongmei Yang. (2021) Downregulation of miR-29c promotes muscle wasting by modulating the activity of leukemia inhibitory factor in lung cancer cachexia. Cancer Cell International 21:1.
Crossref
Crossref
Dandan Chen, Yaoyu Liu, Junqi Chen, Hua Lin, Huijuan Guo, Yifan Wu, Yuan Xu, Yuan Zhou, Wei Zhou, Ruirui Lu, Jiuyao Zhou & Junbiao Wu. (2021) JAK/STAT pathway promotes the progression of diabetic kidney disease via autophagy in podocytes. European Journal of Pharmacology 902, pages 174121.
Crossref
Crossref
Yonghua Li, Huan Jin, Yibing Chen, Ting Huang, Yanjun Mi & Zhengzhi Zou. (2021) Cancer cachexia: molecular mechanism and pharmacological management. Biochemical Journal 478:9, pages 1663-1688.
Crossref
Crossref
Ana Pereira, Joaquim Costa Pereira & Sandra F. Martins. (2021) Clinical Impact of Sarcopenia on Gastrointestinal Tumors. Gastrointestinal Disorders 3:1, pages 51-60.
Crossref
Crossref
Simonetta Ausoni, Sara Calamelli, Salvatore Saccà & Giuseppe Azzarello. (2020) How progressive cancer endangers the heart: an intriguing and underestimated problem. Cancer and Metastasis Reviews 39:2, pages 535-552.
Crossref
Crossref
Jialin Li, Yinan Deng, Menghui Zhang, Yusheng Cheng, Xin Zhao & Zhigang Ji. (2019) Prognostic value of radiologically determined sarcopenia prior to treatment in urologic tumors. Medicine 98:38, pages e17213.
Crossref
Crossref
Ilaria Trestini, Anastasios Gkountakos, Luisa Carbognin, Alice Avancini, Massimo Lanza, Alessio Molfino, Simonetta Friso, Vincenzo Corbo, Giampaolo Tortora, Aldo Scarpa, Michele Milella, Emilio Bria & Sara Pilotto. (2019) Muscle derangement and alteration of the nutritional machinery in NSCLC. Critical Reviews in Oncology/Hematology 141, pages 43-53.
Crossref
Crossref
Thomas K. Sin, James Z. Zhu, Guohua Zhang & Yi-Ping Li. (2019) p300 Mediates Muscle Wasting in Lewis Lung Carcinoma. Cancer Research 79:7, pages 1331-1342.
Crossref
Crossref
Leon Naar, Despoina-Amalia Spanomichou & Panteleimon Vassiliu. (2019) Comment on “Muscle wasting and survival following pre-operative chemoradiotherapy for locally advanced rectal carcinoma”. Clinical Nutrition 38:2, pages 962-963.
Crossref
Crossref
Susan C. Kandarian, Rachel L. Nosacka, Andrea E. Delitto, Andrew R. Judge, Sarah M. Judge, John D. Ganey, Jesse D. Moreira & Robert W. Jackman. (2018) Tumour-derived leukaemia inhibitory factor is a major driver of cancer cachexia and morbidity in C26 tumour-bearing mice. Journal of Cachexia, Sarcopenia and Muscle 9:6, pages 1109-1120.
Crossref
Crossref
Jeroen L.A. van Vugt, Robert R.J. Coebergh van den Braak, Henk J.W. Schippers, Kevin M. Veen, Stef Levolger, Ron W.F. de Bruin, Marcel Koek, Wiro J. Niessen, Jan N.M. IJzermans & François E.J.A. Willemsen. (2018) Contrast-enhancement influences skeletal muscle density, but not skeletal muscle mass, measurements on computed tomography. Clinical Nutrition 37:5, pages 1707-1714.
Crossref
Crossref
S. Levolger, M.G. van Vledder, W.J. Alberda, C. Verhoef, R.W.F. de Bruin, J.N.M. IJzermans & J.W. Burger. (2018) Muscle wasting and survival following pre-operative chemoradiotherapy for locally advanced rectal carcinoma. Clinical Nutrition 37:5, pages 1728-1735.
Crossref
Crossref
Jeroen L.A. van Vugt, Robert R.J. Coebergh van den Braak, Zarina S. Lalmahomed, Wietske W. Vrijland, Jan W.T. Dekker, David D.E. Zimmerman, Wouter J. Vles, Peter-Paul L.O. Coene & Jan N.M. IJzermans. (2018) Impact of low skeletal muscle mass and density on short and long-term outcome after resection of stage I-III colorectal cancer. European Journal of Surgical Oncology 44:9, pages 1354-1360.
Crossref
Crossref
Sarthak Gupta, Robinder J.S. Dhillon & Sarfaraz Hasni. (2018) Sarcopenia. Rheumatic Disease Clinics of North America 44:3, pages 393-404.
Crossref
Crossref
Jeroen L. A. van Vugt, Stefan Buettner, Louise J. M. Alferink, Niek Bossche, Ron W. F. de Bruin, Sarwa Darwish Murad, Wojciech G. Polak, Herold J. Metselaar & Jan N. M. IJzermans. (2018) Low skeletal muscle mass is associated with increased hospital costs in patients with cirrhosis listed for liver transplantation-a retrospective study. Transplant International 31:2, pages 165-174.
Crossref
Crossref
Jeroen L. A. van Vugt, Stefan Buettner, Stef Levolger, Robert R. J. Coebergh van den Braak, Mustafa Suker, Marcia P. Gaspersz, Ron W. F. de Bruin, Cornelis Verhoef, Casper H. C. van Eijck, Niek Bossche, Bas Groot Koerkamp & Jan N. M. IJzermans. (2017) Low skeletal muscle mass is associated with increased hospital expenditure in patients undergoing cancer surgery of the alimentary tract. PLOS ONE 12:10, pages e0186547.
Crossref
Crossref
Guohua Zhang, Zhelong Liu, Hui Ding, Yong Zhou, Hoang Anh Doan, Ka Wai Thomas Sin, Zhiren J. Zhu, Rene Flores, Yefei Wen, Xing Gong, Qingyun Liu & Yi-Ping Li. (2017) Tumor induces muscle wasting in mice through releasing extracellular Hsp70 and Hsp90. Nature Communications 8:1.
Crossref
Crossref
Janneke van Grinsven, Jeroen L. A. van Vugt, Arvind Gharbharan, Thomas L. Bollen, Marc G. Besselink, Hjalmar C. van Santvoort, Casper H. J. van Eijck & Djamila Boerma. (2017) The Association of Computed Tomography-Assessed Body Composition with Mortality in Patients with Necrotizing Pancreatitis. Journal of Gastrointestinal Surgery 21:6, pages 1000-1008.
Crossref
Crossref
Guohua Zhang, Zhelong Liu, Hui Ding, Hongyu Miao, Jose M. Garcia & Yi-Ping Li. (2017) Toll-like receptor 4 mediates Lewis lung carcinoma-induced muscle wasting via coordinate activation of protein degradation pathways. Scientific Reports 7:1.
Crossref
Crossref
Zaira Aversa, Paola Costelli & Maurizio Muscaritoli. (2017) Cancer-induced muscle wasting: latest findings in prevention and treatment. Therapeutic Advances in Medical Oncology 9:5, pages 369-382.
Crossref
Crossref
Janina A Vaitkus & Francesco S Celi. (2016) The role of adipose tissue in cancer-associated cachexia. Experimental Biology and Medicine 242:5, pages 473-481.
Crossref
Crossref
Robinder J.S. Dhillon & Sarfaraz Hasni. (2017) Pathogenesis and Management of Sarcopenia. Clinics in Geriatric Medicine 33:1, pages 17-26.
Crossref
Crossref
Hidetaka Wakabayashi & Kunihiro Sakuma. 2017. The Plasticity of Skeletal Muscle. The Plasticity of Skeletal Muscle
155
178
.
Jann Arends, Ulrich Hacker, David Blum & Stephan von HaehlingStephan von Haehling. 2018. Kachexie bei Tumorerkrankungen. Kachexie bei Tumorerkrankungen
114
132
.
S A Purcell, S A Elliott, V E Baracos, Q S C Chu & C M Prado. (2016) Key determinants of energy expenditure in cancer and implications for clinical practice. European Journal of Clinical Nutrition 70:11, pages 1230-1238.
Crossref
Crossref
J.L.A. van Vugt, S. Levolger, R.W.F. de Bruin, J. van Rosmalen, H.J. Metselaar & J.N.M. IJzermans. (2016) Systematic Review and Meta-Analysis of the Impact of Computed Tomography–Assessed Skeletal Muscle Mass on Outcome in Patients Awaiting or Undergoing Liver Transplantation. American Journal of Transplantation 16:8, pages 2277-2292.
Crossref
Crossref
Mario Thevis, Tiia Kuuranne, Katja Walpurgis, Hans Geyer & Wilhelm Schänzer. (2016) Annual banned-substance review: analytical approaches in human sports drug testing. Drug Testing and Analysis 8:1, pages 7-29.
Crossref
Crossref
S Levolger, J L A van Vugt, R W F de Bruin & J N M IJzermans. (2015) Systematic review of sarcopenia in patients operated on for gastrointestinal and hepatopancreatobiliary malignancies. British Journal of Surgery 102:12, pages 1448-1458.
Crossref
Crossref
Stef Levolger, Mark G. van Vledder, Rahat Muslem, Marcel Koek, Wiro J. Niessen, Rob A. de Man, Ron W. F. de Bruin & Jan N. M. Ijzermans. (2015) Sarcopenia impairs survival in patients with potentially curable hepatocellular carcinoma. Journal of Surgical Oncology 112:2, pages 208-213.
Crossref
Crossref